Protein aggregates can decrease the potency of your gene therapy therapeutic. Check out our AAV Analytics application page to learn how to efficiently monitor them.
Submit the form below to get new application and product info, including our new instrument that will be introduced this month
First Name *
Last Name *
Formulation developmentLate stage formulationDevelopability assessmentProcess developmentAnalytical DevelopmentQuality ControlPre-clinical studiesReagent qualityPre-Formulation
Protein therapeuticsVaccinesViral particlesNanoparticlesSmall moleculesPeptidesCellsOther
I’m interested in monitoring:
Extrinsic particlesIntrinsic particlesInherent particles
My throughput needs are:
<10 samples/week10-100 samples/week100-500 samples/week500 samples/week
Yes, I'm interested in receiving emails from Halo on the latest products and application areas.No thanks, don't send me promotional emails.
Don't worry, we don't like spam either. You can opt-out of emails at any time.